Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)

Philippe Saiag, Ralf Gutzmer, P A Ascierto, M. De Maio, Jean Jacques Grob, Pawel Murawa, B Dreno, M. Ross, J. Weber, Axel Hauschild, P. Rutkowski, Evgeny Levchenko, A. Van Enk, Laurent Misery, C Vanden Abeele, I Vojtek, O Peeters, V G Brichard, P. Therasse

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)'. Together they form a unique fingerprint.

Medicine & Life Sciences